Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
grade F 11.63 1.84% 0.21
TEVA closed up 1.84 percent on Friday, May 17, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical TEVA trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.84%
Calm After Storm Range Contraction 1.84%
Lower Bollinger Band Walk Weakness 1.84%
Wide Bands Range Expansion 1.84%
Below Lower BB Weakness 1.84%

Older signals for TEVA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Medicine Chemistry Cancer Pharmaceutical Pain Drugs Medication Pharmaceutical Products Multiple Sclerosis Lymphoma Parkinson's Disease Active Pharmaceutical Ingredients Asthma Leukemia Chronic Lymphocytic Leukemia Treatment Of Parkinson's Disease Obstructive Sleep Apnea Fentanyl Generic Pharmaceutical Products Muscle Spasm Party Products Urinary Incontinence Chronic Myeloid Leukemia Infertility Menopause Narcolepsy Teva Pharmaceutical Industries Treatment Of Chronic Lymphocytic Leukemia
Is TEVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.96
52 Week Low 11.26
Average Volume 12,571,755
200-Day Moving Average 19.1149
50-Day Moving Average 14.9867
20-Day Moving Average 14.15
10-Day Moving Average 13.175
Average True Range 0.6101
ADX 43.26
+DI 7.5739
-DI 43.7118
Chandelier Exit (Long, 3 ATRs ) 13.8897
Chandelier Exit (Short, 3 ATRs ) 13.0903
Upper Bollinger Band 16.9875
Lower Bollinger Band 11.3125
Percent B (%b) 0.06
BandWidth 40.106007
MACD Line -0.9308
MACD Signal Line -0.5869
MACD Histogram -0.3439
Fundamentals Value
Market Cap 11.81 Billion
Num Shares 1.02 Billion
EPS -6.11
Price-to-Earnings (P/E) Ratio -1.90
Price-to-Sales 0.60
Price-to-Book 0.57
PEG Ratio -0.47
Dividend 1.10
Dividend Yield 9.46%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.33
Resistance 3 (R3) 12.30 12.04 12.21
Resistance 2 (R2) 12.04 11.87 12.06 12.17
Resistance 1 (R1) 11.84 11.76 11.94 11.86 12.13
Pivot Point 11.58 11.58 11.63 11.59 11.58
Support 1 (S1) 11.37 11.40 11.48 11.40 11.13
Support 2 (S2) 11.11 11.29 11.13 11.09
Support 3 (S3) 10.91 11.11 11.05
Support 4 (S4) 10.93